CIK: 0001542339
Total reported value
$250.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PSDVUSD | Eyepoint Pharmaceuticals INC | Stock-Other | 39.63% | — | — | |
| 2 | AXGN | Axogen INC | Stock-Other | 27.74% | — | -11.31% | |
| 3 | RVNCEUR | Revance Therapeutics INC | Stock-Other | 24.99% | — | — | |
| 4 | MNOV | Medicinova INC | Stock-Other | 6.50% | +0.14% | — | |
| 5 | ELGXEUR | Endologix INC | Stock-Other | 0.80% | — | — | |
| 6 | ✓ | Gyre Therapeutics INC Com | Stock-Other | 0.33% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | MNOV | Medicinova INC | +1.7% | — | Unchanged |
| 2 | AXGN | Axogen INC | -1% | -11.31% | Trim |
| 3 | RVNCEUR | Revance Therapeutics INC | -1.2% | — | Unchanged |
| 4 | ✓ | Psivida CORP | — | EXIT | Sold out |
| 5 | PSDVUSD | Eyepoint Pharmaceuticals INC | — | NEW | New buy |
| 6 | ✓ | Corium Intl INC | — | — | Unchanged |
| 7 | ELGXEUR | Endologix INC | — | NEW | New buy |
| 8 | ✓ | Endologix INC | — | EXIT | Sold out |
| 9 | ✓ | Catalyst Biosciences INC | — | EXIT | Sold out |
| 10 | ✓ | Gyre Therapeutics INC Com | — | NEW | New buy |
| 11 | ACUR | Acura Pharmaceuticals INC | — | EXIT | Sold out |